Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder

Overview of attention for article published in Drug Design, Development and Therapy, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

patent: 2 patents
facebook: 1 Facebook page

Citations

dimensions_citation: 17 Dimensions

Readers on

mendeley: 47 Mendeley

Summary News X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Fdez. Sastre y Rojo Psiquiatras, 10 Mar 2015

¿UN NUEVO FÁRMACO PARA EL TDAH?. El MAZINDOL, un fármaco agonista catecolaminérgico, que se usa en el tratamiento de la obesidad…